Related Experiment Videos
Current perspectives on familial Mediterranean fever
Galip Guz1, Mehmet Kanbay, M Akif Ozturk
1Department of Internal Medicine/Nephrology, Gazi University Faculty of Medicine, Ankara, Turkey. galip_guz@hotmail.com
Purpose Of Review:
The gene responsible for familial Mediterranean Fever (FMF), MEditerranean FeVer (MEFV), was identified two decades ago; however, only recent studies have shed light on its pathogenesis. This review focuses on recent studies that have led us to more fully understand FMF pathogenesis.
Recent Findings:
The vast majority of FMF-associated mutations are located in the B30.2 (SPRY) domain, which functions as a ligand binding or a signal transduction domain, at the carboxy terminus of the protein. As a result, B30.2 mutations may lead to postponed apoptosis and inflammation due to the reduced ability of pyrin to control interleukin-1beta (IL-1beta) activation. Development of AA amyloidosis is rare in FMF patients without amyloidogenic single nucleotide polymorphisms (SNPs) (713T allele) of the SAA1 gene. High macrophage inflammatory protein-1alpha levels during FMF attacks might be responsible for the enhancement of T-cell mediated immunity in FMF. IL-1beta-511 (C/T), IL-1beta+3953 (C/T) and IL-1Ra VNTR polymorphisms were not associated with the development of amyloid in FMF patients.
Summary:
Future studies should focus on defining the impact of MEFV and other mutations on the pathological course of FMF, and to understand the exact pathophysiology of those patients who are unresponsive to colchicine, which may help to develop novel therapeutic options for the management and improvement of prognosis.
Insights
Familial Mediterranean Fever (FMF) pathogenesis is better understood through recent studies on MEFV gene mutations. These findings highlight pyrin
Area of Science:
- Genetics and Molecular Biology
- Immunology
- Rheumatology
Background:
- Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disorder.
- The MEFV gene, identified two decades ago, is responsible for FMF.
- Recent research has significantly advanced the understanding of FMF pathogenesis.
Purpose of the Study:
- To review recent studies on FMF pathogenesis.
- To elucidate the role of MEFV gene mutations in FMF.
- To understand the molecular mechanisms underlying FMF and its complications.
Main Methods:
- Review of recent scientific literature on FMF.
- Analysis of mutation data in the MEFV gene, particularly in the B30.2 (SPRY) domain.
- Examination of genetic polymorphisms and their association with FMF and amyloidosis.
Main Results:
- Most FMF mutations occur in the B30.2 (SPRY) domain of pyrin, affecting IL-1beta activation and leading to inflammation.
- AA amyloidosis is uncommon in FMF patients lacking specific SAA1 gene polymorphisms.
- Elevated macrophage inflammatory protein-1alpha levels may enhance T-cell immunity during FMF attacks.
Conclusions:
- Further research is needed to define the impact of MEFV mutations on FMF progression.
- Understanding the pathophysiology in colchicine-unresponsive patients is crucial for developing new therapies.
- Novel therapeutic strategies may improve FMF management and patient prognosis.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Pericarditis III: Medical Management
Myocarditis I: Introduction
Pericarditis I: Introduction
Malaria